Exopharm's products include Plexaris, exosomes derived from human platelets, and Exomeres, exosomes from stem cells.Exosomes are extracellular vesicles involved in cell-cell communication and transmission of disease states through transfer of protein, RNA, lipids and microRNA. Exosomes are thought to mediate some of the regenerative effects of stem cells and provide a cell-free therapeutic agent with therapeutic benefits.The company aims to treat diseases such as dry Age Related Macular Degeneration (AMD), tendinopathy, arthritis, cardiac repair, neurodegeneration and aging.
Exopharm's proprietary LEAP Technology provides a key step in the downstream manufacturing process to isolate and purify exosomes from adult stem cells and other sources which claims to address existing limitations in exosome purification processes. Exopharm's technology is designed for the manufacture of a proprietary exosome product at clinical and then pharmaceutical grade and scale.
The Stem Cell Exomere Program is a partnership between RoosterBio and Exopharm to develop and implement a standardized, scalable, commercially-viable biomanufacturing process and a cGMP-compliant Exomere product (exosomes) for regenerative medicine applications.
Exopharm was founded.
Gregor Lichtfuss, MSc, DTMPH
Technology Co-Founder and Chief Operating Officer
Ian Dixon, PhD, MBA, MAICD
Company Founder, Technology Co-Founder and Managing Director
Australia's Exopharm raises A$7M in IPO
Exopharm company spun out to commercialise a completely new type of nano-drug for regenerative medicine
Stem Cell Exomere Program announced by RoosterBio and Exopharm
Documentaries, videos and podcasts
- Cluster: Stem cell technologyTechnology used for isolating, generating, growing and controlling the differentiation of stem cells into specialized cells and the application of stem cell technology for medical and non-medical purposes such as producing meat through cellular agriculture.
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Regenerative medicineBranch of research dealing with the process of replacing, engineering, or regenerating biological units to (re-)establish normal function
- RoosterBioRoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.